The stock price of Inmode Ltd (NASDAQ: INMD) has jumped by 1.08 compared to previous close of 17.06. Despite this, the company has seen a gain of 0.55% in its stock price over the last five trading days. seekingalpha.com reported 2024-12-12 that InMode Ltd. demonstrates impressive net income growth from non-invasive surgical products, with new platforms Define and Envision expected to drive future business growth. The company’s innovative technologies in plastic surgery, dermatology, gynecology, and ophthalmology, along with ongoing stock repurchases, make InMode a compelling buy. Strong financials show consistent income growth and significant cash flow, with minimal liabilities, indicating a robust financial position and undervaluation.
Is It Worth Investing in Inmode Ltd (NASDAQ: INMD) Right Now?
Inmode Ltd (NASDAQ: INMD) has a price-to-earnings ratio that is above its average at 9.32x. The stock has a 36-month beta value of 2.11. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as “overweight,” 4 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for INMD is 74.84M, and at present, short sellers hold a 8.02% of that float. On December 26, 2024, the average trading volume of INMD was 1.10M shares.
INMD’s Market Performance
INMD stock saw a decrease of 0.55% in the past week, with a monthly decline of -11.65% and a quarterly a decrease of 0.32%. The volatility ratio for the week is 3.69%, and the volatility levels for the last 30 days are 3.08% for Inmode Ltd (INMD). The simple moving average for the last 20 days is -5.37% for INMD’s stock, with a simple moving average of -3.53% for the last 200 days.
Analysts’ Opinion of INMD
Many brokerage firms have already submitted their reports for INMD stocks, with BTIG Research repeating the rating for INMD by listing it as a “Buy.” The predicted price for INMD in the upcoming period, according to BTIG Research is $25 based on the research report published on October 17, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see INMD reach a price target of $19, previously predicting the price at $21. The rating they have provided for INMD stocks is “Hold” according to the report published on July 23rd, 2024.
UBS gave a rating of “Neutral” to INMD, setting the target price at $24 in the report published on November 03rd of the previous year.
INMD Trading at -5.48% from the 50-Day Moving Average
After a stumble in the market that brought INMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.65% of loss for the given period.
Volatility was left at 3.08%, however, over the last 30 days, the volatility rate increased by 3.69%, as shares sank -11.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.46% upper at present.
During the last 5 trading sessions, INMD fell by -0.52%, which changed the moving average for the period of 200-days by -20.50% in comparison to the 20-day moving average, which settled at $18.21. In addition, Inmode Ltd saw -22.46% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for INMD
Current profitability levels for the company are sitting at:
- 0.32 for the present operating margin
- 0.82 for the gross margin
The net margin for Inmode Ltd stands at 0.36. The total capital return value is set at 0.18. Equity return is now at value 21.04, with 19.00 for asset returns.
Currently, EBITDA for the company is 196.28 million with net debt to EBITDA at -1.17. When we switch over and look at the enterprise to sales, we see a ratio of 3.06. The receivables turnover for the company is 6.5for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.68.
Conclusion
To sum up, Inmode Ltd (INMD) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
